Vanguard Portfolio Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66B Buy
34,059,967
+609,409
+2% +$49.2M 0.12% 165
2026
Q1
$2.9B Buy
+33,450,558
New +$3.2B 0.15% 117

Other funds holding MDT

Vanguard Portfolio Management's MDT Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Medtronic (MDT) stake by 1.8% in Q2 2026, buying an estimated $49.2M and bringing the position to 34,059,967 shares worth $2.66B. The position accounts for 0.12% of the portfolio, ranked #165.

Vanguard Portfolio Management first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.9B in Q1 2026. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vanguard Portfolio Management held 34,059,967 shares of Medtronic worth $2.66B as of Q2 2026.
  • Vanguard Portfolio Management bought 609,409 Medtronic shares in Q2 2026, an estimated $49.2M.
  • Medtronic made up 0.12% of Vanguard Portfolio Management's portfolio in Q2 2026, its #165 holding.
  • Vanguard Portfolio Management first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Medtronic position peaked at $2.9B in Q1 2026.
  • 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.